Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

CAFC
  • US 6,646,006 B2
  • Filed: 02/01/2002
  • Issued: 11/11/2003
  • Est. Priority Date: 06/11/1993
  • Status: Expired due to Fees
First Claim
Patent Images

1. A composition comprising L-arginine or a physiologically acceptable salt thereof in an amount sufficient to enhance nitric oxide production and grape skin extract, wherein said composition is in a form suitable for oral administration selected from the group consisting of a pill, tablet, powder, or capsule.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×